List of insiders holdings for Astria Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Xontogeny LLC Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner | 2021-06-25 17:01:11 | 7,687,185 0 | 7,687,185 | Form 13D |
| PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director | 2024-02-05 17:02:33 | 0 6,485,420 | 6,485,420 | Form 4 |
| SVLSF V LLC SV Life Sciences Fund V (GP) LP SV LIFE SCIENCES FUND V LP SV Life Sciences Fund V Strategic Partners L.P. 10% Owner | 2017-02-07 06:11:32 | 2,857,667 0 | 2,857,667 | Form 13D |
| Clarus Lifesciences II L.P. Clarus Ventures II GP L.P. Clarus Ventures II LLC 10% Owner | 2018-04-04 16:42:28 | 2,024,783 0 | 2,024,783 | Form 13D |
| Laufer Ron Director 10% Owner | 2015-06-30 18:45:19 | 11,094 1,632,652 | 1,643,746 | Form 4 |
| MedImmune Ventures Inc. 10% Owner | 2015-06-30 18:45:33 | 1,632,652 0 | 1,632,652 | Form 4 |
| Advanced Technology Ventures VIII LP ATV Associates VIII L.L.C. 10% Owner | 2018-02-14 15:33:14 | 1,133,943 0 | 1,133,943 | Form 13G |
| Milne Jill C. CEO and President | 2024-02-12 16:06:04 | 534,600 0 | 534,600 | Form 4 |
| Jirousek Michael Chief Scientific Officer | 2015-06-30 18:48:03 | 246,093 0 | 246,093 | Form 4 |
| Matthews Andrea Chief Business Officer | 2024-02-12 16:05:47 | 175,000 0 | 175,000 | Form 4 |
| Komjathy Andrew Chief Commercial Officer | 2024-02-12 16:05:35 | 175,000 0 | 175,000 | Form 4 |
| Harshbarger Benjamin Chief Legal Officer | 2024-02-12 16:05:26 | 175,000 0 | 175,000 | Form 4 |
| Clauser Noah Chief Financial Officer | 2024-02-12 16:05:15 | 175,000 0 | 175,000 | Form 4 |
| Hibben Edward K. Chief Business Officer | 2018-02-09 16:01:34 | 100,000 0 | 100,000 | Form 4 |
| Morabito Christopher Chief Medical Officer | 2024-04-03 16:05:13 | 80,000 0 | 80,000 | Form 4 |
| Donovan Joanne M. CMO; SVP Clinical Development | 2020-02-14 15:00:22 | 60,000 0 | 60,000 | Form 4 |
| Nichols Andrew John Chief Scientific Officer | 2022-03-03 19:18:58 | 55,000 0 | 55,000 | Form 4 |
| Sanderson Ian C. Chief Financial Officer | 2016-02-16 18:27:42 | 52,000 0 | 52,000 | Form 4 |
| Modi Rick Chief Business Officer | 2016-09-13 17:24:54 | 45,000 0 | 45,000 | Form 4/A |
| Cunnane Deirdre A. Chief Legal Officer | 2019-02-15 08:42:34 | 40,000 0 | 40,000 | Form 4 |
| AGARWAL SUNIL Director | 2024-04-09 08:11:28 | 28,200 0 | 28,200 | Form 4 |
| BATE KENNETH Director | 2023-06-06 08:00:47 | 14,100 0 | 14,100 | Form 4 |
| Beck Joanne T. Director | 2023-06-06 08:02:29 | 14,100 0 | 14,100 | Form 4 |
| Callori Fred Director | 2023-06-06 08:04:46 | 14,100 0 | 14,100 | Form 4 |
| Cole Hugh M Director | 2023-06-06 08:05:20 | 14,100 0 | 14,100 | Form 4 |
| Violin Jonathan Director | 2023-06-06 08:06:13 | 14,100 0 | 14,100 | Form 4 |
| LAPOINTE ANTHONY GREGG Director | 2023-06-06 08:06:37 | 14,100 0 | 14,100 | Form 4 |
| KISHBAUCH MICHAEL D Director | 2023-06-06 08:06:57 | 14,100 0 | 14,100 | Form 4 |
| Ross Michael Jay Director | 2018-06-07 18:19:58 | 14,000 0 | 14,000 | Form 4 |
| George Jean Director | 2018-06-07 18:04:23 | 14,000 0 | 14,000 | Form 4 |
| ADELMAN BURT A Director | 2020-06-12 11:44:42 | 7500 0 | 7500 | Form 4 |
| GALAKATOS NICHOLAS Director | 2016-08-05 16:09:12 | 6500 0 | 6500 | Form 4 |